These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 18221550

  • 1. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Nusbaumer C, Brutsche M, Müller B.
    BMC Pulm Med; 2008 Jan 26; 8():1. PubMed ID: 18221550
    [Abstract] [Full Text] [Related]

  • 2. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis.
    Habib G, Jabbour A, Salman J, Hakim G, Haddad H.
    J Clin Anesth; 2013 Dec 26; 25(8):629-33. PubMed ID: 23988802
    [Abstract] [Full Text] [Related]

  • 3. Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial.
    Schuetz P, Leuppi JD, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Mueller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J.
    Eur J Endocrinol; 2015 Jul 26; 173(1):19-27. PubMed ID: 25855628
    [Abstract] [Full Text] [Related]

  • 4. A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic-Pituitary-Adrenal Axis.
    Arshad MF, Elder C, Newell-Price J, Ross R, Debono M.
    J Clin Endocrinol Metab; 2024 Oct 15; 109(11):e2031-e2037. PubMed ID: 38298131
    [Abstract] [Full Text] [Related]

  • 5. [Assessment of the hypothalamic-hypophyseal-adrenal axis in patients with chronic obstructive lung disease. Comparison of inhalant with systemic glucocorticoid therapy].
    Santen RT, Schlaghecke R, Schwalen A.
    Dtsch Med Wochenschr; 1997 Apr 18; 122(16):497-503. PubMed ID: 9162622
    [Abstract] [Full Text] [Related]

  • 6. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
    Suliman AM, Smith TP, Labib M, Fiad TM, McKenna TJ.
    Clin Endocrinol (Oxf); 2002 Apr 18; 56(4):533-9. PubMed ID: 11966747
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers.
    Neidert S, Schuetz P, Mueller B, Christ-Crain M.
    Eur J Endocrinol; 2010 May 18; 162(5):943-9. PubMed ID: 20142368
    [Abstract] [Full Text] [Related]

  • 8. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    Clin Endocrinol (Oxf); 1995 Sep 18; 43(3):283-90. PubMed ID: 7586596
    [Abstract] [Full Text] [Related]

  • 9. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test.
    Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N.
    Clin Endocrinol (Oxf); 2000 May 18; 52(5):633-40. PubMed ID: 10792344
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ.
    Cochrane Database Syst Rev; 2017 Nov 06; 11(11):CD008727. PubMed ID: 29106702
    [Abstract] [Full Text] [Related]

  • 11. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, Pastore G.
    Pediatr Blood Cancer; 2008 Mar 06; 50(3):537-41. PubMed ID: 17828747
    [Abstract] [Full Text] [Related]

  • 12. PREDICTING RECOVERY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER PROLONGED GLUCOCORTICOID USE.
    Leong SH, Shander S, Ratnasingam J.
    Endocr Pract; 2018 Jan 06; 24(1):14-20. PubMed ID: 29368966
    [Abstract] [Full Text] [Related]

  • 13. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
    Crit Care Med; 2001 Feb 06; 29(2):310-6. PubMed ID: 11246311
    [Abstract] [Full Text] [Related]

  • 14. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct 06; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic Pituitary Adrenocortical Axis Suppression following a Single Epidural Injection of Methylprednisolone Acetate.
    Abdul AJ, Ghai B, Bansal D, Sachdeva N, Bhansali A, Dhatt SS.
    Pain Physician; 2017 Nov 06; 20(7):E991-E1001. PubMed ID: 29149147
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1995 Oct 06; 43(4):425-31. PubMed ID: 7586616
    [Abstract] [Full Text] [Related]

  • 17. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test.
    Lević Z, Micić D, Nikolić J, Stojisavljević N, Sokić D, Janković S, Kendereski A, Mavra M.
    J Endocrinol Invest; 1996 Jan 06; 19(1):30-4. PubMed ID: 8851689
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K.
    Endocr J; 1993 Oct 06; 40(5):581-9. PubMed ID: 7951524
    [Abstract] [Full Text] [Related]

  • 19. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency.
    Lee MT, Won JG, Lee TI, Yang HJ, Lin HD, Tang KT.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec 06; 65(12):580-7. PubMed ID: 12636203
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 06; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.